Collectively, these results suggest that Galectin-1 interaction with FAM289 promotes FAM289 protein into the cell nucleus and activates the ERK pathway, thereby upregulating DNMTs expression, and nuclear FAM289-Galectin-1 interaction controls the tumor-promoting effects of FAM289 in malignant glioma. This evidence concerns the gene LGALS1 and malignant glioma.